# FDA recall D-0852-2016

> **Baxter Healthcare Corp.** · Class II · drug recall initiated 2016-04-12.

## Product

Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, Il 60015, NDC 10019-075-87

## Reason for recall

Discoloration:  presence of atypical yellow discoloration of the solution .

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0852-2016
- **Recalling firm:** Baxter Healthcare Corp.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-04-12
- **Report date:** 2016-05-18
- **Termination date:** 2017-03-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Deerfield, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0852-2016

## Citation

> AI Analytics. FDA recall D-0852-2016. Retrieved 2026-05-31 from https://api.ai-analytics.org/recall/D-0852-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
